Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 19 peer-reviewed journal articles Updated

Standard of Care & Treatment Options for Brain AVMs

At a Glance

Brain AVM treatment is highly personalized based on whether the AVM has ruptured and its Spetzler-Martin grade. Options include microsurgical resection, stereotactic radiosurgery, embolization, or watchful waiting. A multidisciplinary care team will determine the safest approach for your specific case.

Choosing a treatment path for a brain AVM is a highly personal decision. There is no “one-size-fits-all” answer. Instead, your care team will look at whether your AVM has already bled and its Spetzler-Martin (SM) Grade to determine the safest strategy [1][2].

Four Main Treatment Paths

Today, most patients are treated using a “multimodal” approach—meaning more than one of these options might be used together [2]:

  1. Microsurgical Resection (Surgery): A neurosurgeon removes the AVM by carefully disconnecting the blood vessels. This is the fastest way to “cure” an AVM, as the risk of bleeding is eliminated the moment the nidus is removed [3][4].
  2. Stereotactic Radiosurgery (SRS/Gamma Knife): This is not “surgery” with a knife. Instead, highly focused beams of radiation are aimed at the AVM. During this outpatient procedure, your head is held completely still (often using a specialized frame or mask), but you are awake and no incisions are made [5]. Over 2–3 years, the radiation causes the vessels to thicken and eventually close off. This is often used for AVMs that are in deep or “eloquent” areas where traditional surgery is too risky [5][6].
  3. Endovascular Embolization: A specialist threads a catheter through your arteries and injects a “glue” or liquid embolic agent to block off parts of the AVM [7]. This is rarely used alone to cure an AVM; instead, it is usually done to shrink the AVM before surgery or radiation [2].
  4. Conservative Medical Management: This involves monitoring the AVM with regular scans and treating symptoms like headaches or seizures with medication [8].

The ARUBA Trial: A Turning Point

If your AVM is unruptured (has not bled), your doctor will likely mention the ARUBA trial [8].

  • The Findings: This major study compared interventional treatment (surgery, radiation, or embolization) against medical management alone for unruptured AVMs. It concluded that for many patients, the risk of having a stroke or death from the treatment itself was higher than the risk of just living with the AVM over a 3-year period [8][9].
  • The Controversy: Many specialists criticize ARUBA because it had a short follow-up (3 years). Since AVMs carry a lifelong risk of bleeding, a procedure that is “riskier” in year one might be “safer” in year ten [10][11]. Critics also argue the trial grouped all treatments together rather than looking at which patients did best with specific types of surgery [10].

Decision Framework

While every case is unique, your care team generally follows this logic:

Situation Typical Approach Why?
Ruptured AVM Intervention (usually surgery) A previously bled AVM has a significantly higher risk of bleeding again soon [12].
Low-Grade (SM I-II) Unruptured Surgery or SRS These are the “safest” to treat; many patients choose treatment to eliminate the lifelong bleed risk [4][13].
High-Grade (SM IV-V) Unruptured Conservative Management The risks of surgery in these large, complex AVMs often outweigh the benefits [14][15].
Mid-Grade (SM III) Multidisciplinary Review These are the most complex decisions, requiring a customized plan [16].

Note: If you have a high-grade AVM, your team may suggest “volume-staged” radiation, which treats parts of the AVM over several sessions to reduce complications [17]. Regardless of the path, the goal of modern care is multidisciplinary—meaning your surgeon, radiation expert, and interventionalist should all agree on the safest plan for you [18][19].

Return to Home Page

Common questions in this guide

What are the main treatment options for a brain AVM?
The primary treatments for a brain AVM include microsurgical removal (surgery), stereotactic radiosurgery (focused radiation), endovascular embolization, and conservative medical management. Often, a multidisciplinary care team will use a combination of these approaches.
What is the safest treatment for an unruptured brain AVM?
The safest treatment depends on your AVM's size and location, often measured by the Spetzler-Martin grade. For some unruptured AVMs, watchful waiting with medical management may have fewer short-term risks than surgical intervention, though AVMs carry a lifelong risk of bleeding.
How does stereotactic radiosurgery (SRS) work for a brain AVM?
SRS uses highly focused beams of radiation aimed directly at the AVM without making any surgical incisions. Over two to three years, this radiation causes the abnormal blood vessels to thicken and eventually close off completely.
What is endovascular embolization used for in AVM treatment?
Embolization involves threading a catheter through your arteries to inject a specialized glue or liquid agent that blocks off parts of the AVM. It is usually performed to shrink the AVM, making it safer and easier to treat with subsequent surgery or radiation.
How does a ruptured AVM change the treatment plan?
If a brain AVM has ruptured and caused a bleed, it has a significantly higher risk of bleeding again in the near future. Because of this immediate risk, doctors typically recommend prompt intervention, usually surgery, to eliminate the danger.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Given my AVM is unruptured, how do the results of the ARUBA trial apply specifically to my age and health status?
  2. 2.For a person with my Spetzler-Martin grade, what is the 'obliteration rate' (success rate) for surgery versus radiosurgery?
  3. 3.If we choose 'watchful waiting' (medical management), how often will I need follow-up scans and what symptoms should I watch for?
  4. 4.If we use embolization, is it intended to be the final treatment or just a step to prepare for surgery or radiation?
  5. 5.What are the risks of radiation-induced complications if we choose Stereotactic Radiosurgery (SRS)?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (19)
  1. 1

    Influence of preoperative embolisation on resection of brain arteriovenous malformations: cohort study.

    Lee SH, Loan JJ, Downer J, et al.

    Acta neurochirurgica 2024; (166(1)):345 doi:10.1007/s00701-024-06234-4.

    PMID: 39167231
  2. 2

    One and Done: Multimodal Treatment of Pediatric Cerebral Arteriovenous Malformations in a Single Anesthesia Event.

    Schunemann V, Wang JL, Dornbos D, et al.

    World neurosurgery 2019; (130()):e715-e721 doi:10.1016/j.wneu.2019.06.200.

    PMID: 31279921
  3. 3

    Brain Edema after Repeat Gamma Knife Radiosurgery for a Large Arteriovenous Malformation: A Case Report.

    Kim JW, Chung HT, Han MH, et al.

    Experimental neurobiology 2016; (25(4)):191-6 doi:10.5607/en.2016.25.4.191.

    PMID: 27574486
  4. 4

    More II It than Meets the Eye: Outcomes After Single-Fraction Stereotactic Radiosurgery in a Case Series of Low-Grade Arteriovenous Malformations.

    Graffeo CS, Link MJ, Stafford SL, et al.

    Operative neurosurgery (Hagerstown, Md.) 2020; (18(2)):136-144 doi:10.1093/ons/opz153.

    PMID: 31250901
  5. 5

    Efficacy of radiosurgery with and without angioembolization: A subgroup analysis of effectiveness in ruptured versus unruptured arteriovenous malformations - An updated systematic review and meta-analysis.

    Khan H, Sangah AB, Nasir R, et al.

    Surgical neurology international 2024; (15()):467 doi:10.25259/SNI_737_2024.

    PMID: 39777180
  6. 6

    Volume-Staged Gamma Knife Radiosurgery for Large Brain Arteriovenous Malformation.

    El-Shehaby AMN, Reda WA, Abdel Karim KM, et al.

    World neurosurgery 2019; (132()):e604-e612 doi:10.1016/j.wneu.2019.08.065.

    PMID: 31442655
  7. 7

    Endovascular Treatment for Low-Grade (Spetzler-Martin I-II) Brain Arteriovenous Malformations.

    Baharvahdat H, Blanc R, Fahed R, et al.

    AJNR. American journal of neuroradiology 2019; (40(4)):668-672 doi:10.3174/ajnr.A5988.

    PMID: 30792251
  8. 8

    Medical management with interventional therapy versus medical management alone for unruptured brain arteriovenous malformations (ARUBA): final follow-up of a multicentre, non-blinded, randomised controlled trial.

    Mohr JP, Overbey JR, Hartmann A, et al.

    The Lancet. Neurology 2020; (19(7)):573-581 doi:10.1016/S1474-4422(20)30181-2.

    PMID: 32562682
  9. 9

    Brain Arteriovenous Malformations: Status of Open Surgery after A Randomized Trial of Unruptured Brain Arteriovenous Malformations.

    Luther E, Govindarajan V, McCarthy DJ, et al.

    Neurosurgery clinics of North America 2022; (33(4)):443-448 doi:10.1016/j.nec.2022.05.006.

    PMID: 36229131
  10. 10

    Critical Appraisal of Randomized Controlled Trials on Unruptured Brain Arteriovenous Malformations.

    Tasiou A, Brotis AG, Tzerefos C, et al.

    World neurosurgery 2022; (166()):e536-e545 doi:10.1016/j.wneu.2022.07.043.

    PMID: 35863649
  11. 11

    What neurointerventionists think about the treatment of unruptured brain arteriovenous malformations: the complexity of moving towards evidence-based treatment.

    Goyal M, Ospel JM, Kashani N, et al.

    Neuroradiology 2020; (62(4)):411-416 doi:10.1007/s00234-020-02365-4.

    PMID: 31974635
  12. 12

    Overall outcomes following early interventions for intracranial arteriovenous malformations with hematomas.

    Bir SC, Maiti TK, Konar S, Nanda A

    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2016; (23()):95-100 doi:10.1016/j.jocn.2015.05.041.

    PMID: 26321303
  13. 13

    A Ruptured Spetzler and Martin Grade V Arteriovenous Malformation in a Child Treated With Radiotherapy Followed by Embolization: A Case Report and Literature Review.

    Iwatate K, Kikuchi Y, Sato S, et al.

    Cureus 2021; (13(7)):e16605 doi:10.7759/cureus.16605.

    PMID: 34430185
  14. 14

    Stereotactic Radiosurgery for Intermediate (III) or High (IV-V) Spetzler-Martin Grade Arteriovenous Malformations: International Stereotactic Radiosurgery Society Practice Guideline.

    Graffeo CS, Kotecha R, Sahgal A, et al.

    Neurosurgery 2025; (96(2)):298-307 doi:10.1227/neu.0000000000003102.

    PMID: 38989995
  15. 15

    Expert Consensus on the Management of Brain Arteriovenous Malformations.

    Kato Y, Dong VH, Chaddad F, et al.

    Asian journal of neurosurgery 2019; (14(4)):1074-1081 doi:10.4103/ajns.AJNS_234_19.

    PMID: 31903343
  16. 16

    Spetzler-Martin Grade III Arteriovenous Malformations: A Comparison of Modified and Supplemented Spetzler-Martin Grading Systems.

    Frisoli FA, Catapano JS, Farhadi DS, et al.

    Neurosurgery 2021; (88(6)):1103-1110 doi:10.1093/neuros/nyab020.

    PMID: 33582762
  17. 17

    Outcomes of Gamma Knife Radiosurgery in Intracranial Arteriovenous Malformations.

    Shah KG, Beniwal M, Konar SK, et al.

    Neurology India 2026; (74(1)):60-70 doi:10.4103/neurol-india.Neurol-India-D-24-00805.

    PMID: 41510861
  18. 18

    European consensus conference on unruptured brain AVMs treatment (Supported by EANS, ESMINT, EGKS, and SINCH).

    Cenzato M, Boccardi E, Beghi E, et al.

    Acta neurochirurgica 2017; (159(6)):1059-1064 doi:10.1007/s00701-017-3154-8.

    PMID: 28389875
  19. 19

    A Rational Approach to the Management of Cerebral Arteriovenous Malformations.

    Johnson MD, Staarmann B, Zuccarello M

    World neurosurgery 2022; (159()):338-347 doi:10.1016/j.wneu.2021.08.045.

    PMID: 35255633

This page provides educational information about brain AVM treatments, surgical options, and the ARUBA trial. It is not medical advice; always discuss your specific Spetzler-Martin grade and treatment risks with your neurosurgery team.

Get notified when new evidence is published on Brain arteriovenous malformation.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.